Risk factors for prevalent and incident hypertension in rheumatoid arthritis: data from the Canadian Early Arthritis Cohort.

cardiovascular disease cohort comorbidities hypertension rheumatoid arthritis

Journal

Rheumatology advances in practice
ISSN: 2514-1775
Titre abrégé: Rheumatol Adv Pract
Pays: England
ID NLM: 101736676

Informations de publication

Date de publication:
2024
Historique:
received: 21 11 2023
accepted: 29 04 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 19 6 2024
Statut: epublish

Résumé

Hypertension (HTN) is a common comorbidity in RA. This study aimed to explore the prevalence and incidence of HTN and baseline factors associated with incident HTN in early RA (ERA). Data were from the Canadian Early Arthritis Cohort (CATCH), an inception cohort of ERA patients having <1 year of disease duration. HTN was determined by patient- or physician-reported diagnosis, the use of anti-hypertensives and/or blood pressure. Multivariable logistic regression was performed to determine baseline factors associated with prevalent and incident HTN in this population. The study sample included 2052 ERA patients [mean age 55 years (s.d. 14), 71% female). The prevalence of HTN at study enrolment was 26% (23% in females and 34% in males). In both sexes, prevalent HTN was associated with older age, diabetes and hyperlipidaemia. HTN was associated with being overweight or high alcohol consumption in females. Of the RA patients who did not have HTN at enrolment, 24% (364/1518) developed HTN during the median follow-up period of 5 years (range 1-8). Baseline factors significantly associated with incident HTN were older age, being overweight, excess alcohol consumption and having hyperlipidaemia. Incident HTN was associated with high alcohol consumption in males and with hyperlipidaemia in females. RA-associated disease factors and treatments were not significantly associated with prevalent or incident HTN. Early RA patients had a high incidence of hypertension with the highest risk in older patients with traditional cardiovascular risk factors.

Identifiants

pubmed: 38895593
doi: 10.1093/rap/rkae066
pii: rkae066
pmc: PMC11183658
doi:

Types de publication

Journal Article

Langues

eng

Pagination

rkae066

Investigateurs

Pooneh Akhavan (P)
Louis Bessette (L)
Gilles Boire (G)
Vivian Bykerk (V)
Ines Colmegna (I)
Sabrina Fallavollita (S)
Derek Haaland (D)
Boulos Haraoui (B)
Glen Hazlewood (G)
Carol Hitchon (C)
Shahin Jamal (S)
Raman Joshi (R)
Ed Keystone (E)
Bindee Kuriya (B)
Peter Panopalis (P)
Janet Pope (J)
Carter Thorne (C)
Edith Villeneuve (E)
Michel Zummer (M)

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.

Auteurs

Brook Hadwen (B)

Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada.

Saverio Stranges (S)

Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada.
Department of Family Medicine, Western University, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.
Department of Population Health, Luxembourg Institute of Health, Strassen, Luxembourg.

Janet E Pope (JE)

Department of Medicine, Division of Rheumatology, Western University, London, Ontario, Canada.

Susan Bartlett (S)

Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.

Gilles Boire (G)

Department of Medicine, Division of Rheumatology, Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie-Centre Hospitalier Universitaire de Sherbrooke and Université de Sherbrooke, Sherbrooke, Quebec, Canada.

Louis Bessette (L)

Department of Medicine, Division of Rheumatology, Université Laval, Quebec, Quebec, Canada.

Carol A Hitchon (CA)

Department of Internal Medicine, Section of Rheumatology, University of Manitoba, Winnipeg, Manitoba, Canada.

Glen Hazlewood (G)

Department of Medicine, Division of Rheumatology, University of Calgary, Calgary, Alberta, Canada.

Edward C Keystone (EC)

Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada.

Orit Schieir (O)

Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.

Carter Thorne (C)

Centre of Arthritis Excellence, Newmarket, Ontario, Canada.

Diane Tin (D)

Centre of Arthritis Excellence, Newmarket, Ontario, Canada.

Marie-France Valois (MF)

Department of Medicine, Division of Rheumatology, McGill University, Montreal, Quebec, Canada.

Vivian Bykerk (V)

Department of Medicine, Hospital for Special Surgery, Weill Cornell Medical, New York, NY, USA.

Lillian Barra (L)

Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.
Department of Medicine, Division of Rheumatology, Western University, London, Ontario, Canada.

Classifications MeSH